Nasal Sprays, Behavioral Intervention Aid in Treatment of Respiratory Illness
By Elana Gotkine HealthDay Reporter
TUESDAY, July 30, 2024 -- Use of nasal sprays and a behavioral intervention promoting physical activity and stress management can reduce antibiotic use for respiratory illness, according to a study published online July 11 in The Lancet Respiratory Medicine.
Paul Little, M.B.B.S., M.D., from the University of Southampton in the United Kingdom, and colleagues examined the effect of nasal sprays or a behavioral intervention promoting physical activity and stress management on respiratory illness in a randomized trial conducted at 332 general practitioner practices. Eligible adults were randomly assigned to usual care, gel-based spray, saline spray, or a brief behavioral intervention promoting physical activity and stress management (3,451, 3,448, 3,450, and 3,450, respectively).
The researchers found that the mean number of days of illness was 8.2 in the usual care group. The mean number of days of illness was significantly lower in the gel-based spray group and saline spray group (mean, 6.5 and 6.4 days, respectively), but not in the group allocated to the behavioral website (mean, 7.4 days). The most common adverse event was headache or sinus pain in the gel-based group (7.8 percent compared with 4.8, 4.5, and 4.5 percent in the usual care group, saline group, and behavioral intervention group, respectively). Antibiotic use was lower for all interventions compared with usual care (incidence rate ratios, 0.65, 0.69, and 0.74 for the gel-based spray group, saline spray group, and behavioral intervention group, respectively).
"These simple scalable interventions could potentially have an important impact on antimicrobial stewardship, and in reducing the impact of respiratory viruses for patients, the health service, and the wider economy," the authors write.
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2024
Read this next
Methotrexate Noninferior to Prednisone in Pulmonary Sarcoidosis
TUESDAY, May 20, 2025 -- For patients with pulmonary sarcoidosis, methotrexate is noninferior to prednisone with regard to the change from baseline to week 24 in the percentage of...
Use of Composite Allocation Score for Lung Transplant Wait List Improves Outcomes
MONDAY, May 19, 2025 -- Wait-list outcomes for lung transplants have substantially improved in the composite allocation score (CAS) era, according to a study presented at the...
Nasal Endoscopic Surgery Beneficial for Chronic Sinusitis, Nasal Polyps
TUESDAY, May 6, 2025 -- For patients with chronic sinusitis and nasal polyps, nasal endoscopic surgery can remove polyps in a shorter time, with less intraoperative blood loss...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.